|Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults||
||707||All||18 Years and older (Adult, Senior)||NCT01095796||GS-US-236-0102||March 2010||August 2011||September 2014||March 30, 2010||November 11, 2015||October 22, 2012||
|2||NCT02384395||Recruiting||Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection||
||Other / Industry||
||40||All||18 Years and older (Adult, Senior)||NCT02384395||14-0549||PHI 05||September 2015||July 2021||July 2021||March 10, 2015||April 10, 2018||
† Study has passed its completion date and status has not been verified in more than two years.